UBC

Pharmacovigilance (PV) is more critical than ever, as life sciences companies navigate rising adverse event volumes, increasingly complex global regulations, and the ethical implications of AI driven safety monitoring. The demand for proactive, technology-enabled PV solutions has never been higher. That’s why we’re proud to share that 𝗨𝗕𝗖 𝗵𝗮𝘀 𝗯𝗲𝗲𝗻 𝗻𝗮𝗺𝗲𝗱 𝗮 𝘁𝗼𝗽-𝗽𝗲𝗿𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝗽𝗿𝗼𝘃𝗶𝗱𝗲𝗿 in the 𝗘𝘃𝗲𝗿𝗲𝘀𝘁 𝗚𝗿𝗼𝘂𝗽 𝗣𝗩 𝗢𝗽𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝘀 𝗣𝗘𝗔𝗞 𝗠𝗮𝘁𝗿𝗶𝘅® 𝗔𝘀𝘀𝗲𝘀𝘀𝗺𝗲𝗻𝘁—a testament to our deep expertise, comprehensive compliance capabilities, and investment in cutting-edge technology to enhance patient safety. Looking to elevate your PV strategy? Let’s connect and explore how UBC can support your PV needs: https://hubs.li/Q03f-mrx0 #Pharmacovigilance #PatientSafety #PatientsFirst #EverestGroup

Get to know UBC’s Christopher Henry, PhD! He is a Safety Scientist on our pharmacovigilance team who is also applying his background in AI to enhancing automation within our comprehensive suite of safety solutions. Read his full bio at https://hubs.li/Q03bLbry0 #PatientsFirst #Pharmacovigilance #PatientSafety #DrugSafety

Meet Judy Lytle, PhD, MBEE, PMP, UBC’s Executive Director of Study Solutions. Judy’s 15+ years of experience driving and utilizing RWE helps UBC design and operationalize differentiated study design and evidence generation solutions. Get her full bio at https://hubs.li/Q03bLzjd0 #PatientsFirst #PatientAccess #PatientServices #Pharma

In just a few short days, we'll be in San Diego for AAN! Schedule a meeting to learn about expert-driven real-world evidence tailored to specialty patient populations, and safety & risk management solutions that build confidence for prescribers: https://hubs.li/Q03dMx9s0 #AANAM #PatientsFirst

Get to know UBC’s Alix Garcia, PhD! Ms. Garcia is a Safety Scientist on our pharmacovigilance team with expertise in gene therapy, as well as being a peer-reviewed author. Read her full bio at https://hubs.li/Q03bLq7B0 #PatientsFirst #Pharmacovigilance #PatientSafety #DrugSafety

Have you met UBC’s Executive Director of Patient Services Marci Gott? As a registered nurse, Marci brings compassion and experience to her role leading functional teams that help our clients and patients overcome hurdles to access and adherence. Read her full bio at https://hubs.li/Q039jQT00 #PatientsFirst #PatientServices #PatientSupport #PatientAccess

Patient adherence to treatment is a multifaceted challenge, especially for patients prescribed expensive injectable or infusion therapies. Find out how to build a comprehensive approach that includes patient education, financial support, and personalized care: https://hubs.li/Q03d46z_0 #PatientsFirst #PatientSupport #PatientAdherence

Our team is looking forward to learning and participating in the premier neurology event hosted by the American Academy of Neurology. Make us a part of your plan for the event and find out how our evidence development and safety & risk management solutions can support your product: https://hubs.li/Q03d4bRg0 #AANAM #PatientsFirst

Get to know UBC’s Rahul Malhotra! As a global Project Director on our Evidence Development team, Rahul uses his 17 years of industry experience to generate efficiencies in the delivery of UBC’s innovative and modernized study designs. Get his full bio at https://hubs.li/Q03bY6400 #PatientsFirst #ClinicalTrials #ClinicalResearch #RWE

Do you have three minutes? Meet UBC’s Irene Navarro de la Fuente, MSc! As a Safety Scientist, she performs critical PV safety writing and signal detection activities, specializing in cell and gene therapies for oncology and rare disease. Read her full bio at https://hubs.li/Q03bKl9H0 #PatientsFirst #Pharmacovigilance #PatientSafety #DrugSafety